PMID- 20186245
OWN - NLM
STAT- MEDLINE
DCOM- 20100406
LR  - 20220331
IS  - 1175-8716 (Electronic)
IS  - 0028-8446 (Linking)
VI  - 123
IP  - 1309
DP  - 2010 Feb 19
TI  - New Zealand primary implantable cardioverter defibrillator implantation and 
      biventricular pacing guidelines.
PG  - 86-96
AB  - Primary implantation of an implantable Cardioverter Defibrillator (ICD) is 
      recommended for patients with ischaemic or non-ischaemic cardiomyopathy present 
      for at least 3 months, with ejection fraction (EF) = or <30% measured = or >3 
      months after optimal heart failure treatment. Patients should be on maximal heart 
      failure treatment as tolerated for = or >3 and preferably 6 months, and in New 
      York Heart Association (NYHA) Class II or III. They should be = or >3 months 
      remote from any revascularisation procedure or have no clinical symptoms or 
      findings that would make them a candidate for revascularisation. There should be 
      no associated disease reducing survival <18 months. Biventricular pacing is 
      recommended for patients with an EF = or <35% after = or >6 weeks of optimal 
      heart failure treatment, whose QRS duration is >149 ms or is 120-149 ms with two 
      additional criteria for dyssynchrony (aortic pre-ejection delay >140 ms, 
      interventricular mechanical delay >40 ms or delayed activation of the 
      posterolateral left ventricular wall). They should be NYHA Class III, have had no 
      major cardiovascular event in the prior 6 weeks and be in sinus rhythm. There 
      should be no major comorbidity reducing survival <18 months or seriously 
      impairing quality of life.
FAU - Smith, Warren
AU  - Smith W
AD  - Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92024, 
      Auckland 1030, New Zealand. warrens@adhb.govt.nz
CN  - New Zealand Pacing and Electrophysiology Group
LA  - eng
PT  - Consensus Development Conference
PT  - Journal Article
PT  - Practice Guideline
DEP - 20100219
PL  - New Zealand
TA  - N Z Med J
JT  - The New Zealand medical journal
JID - 0401067
SB  - IM
MH  - Cardiac Pacing, Artificial/economics/*standards
MH  - Cardiomyopathies/*therapy
MH  - Cost-Benefit Analysis
MH  - Defibrillators, Implantable/economics/*standards
MH  - Europe
MH  - Heart Failure/*therapy
MH  - Humans
MH  - New Zealand
MH  - Stroke Volume
MH  - United States
RF  - 31
EDAT- 2010/02/27 06:00
MHDA- 2010/04/07 06:00
CRDT- 2010/02/27 06:00
PHST- 2010/02/27 06:00 [entrez]
PHST- 2010/02/27 06:00 [pubmed]
PHST- 2010/04/07 06:00 [medline]
PST - epublish
SO  - N Z Med J. 2010 Feb 19;123(1309):86-96.